These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38583756)

  • 1. Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Edmonston D; Fuchs MAA; Burke EJ; Isakova T; Wolf M;
    Am J Kidney Dis; 2024 Sep; 84(3):349-360.e1. PubMed ID: 38583756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
    Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
    Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.
    Liabeuf S; Ryckelynck JP; El Esper N; Ureña P; Combe C; Dussol B; Fouque D; Vanhille P; Frimat L; Thervet E; Mentaverri R; Prié D; Choukroun G;
    Clin J Am Soc Nephrol; 2017 Dec; 12(12):1930-1940. PubMed ID: 29074818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
    Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ishigami J; Kansal M; Mehta R; Srivastava A; Rahman M; Dobre M; Al-Kindi SG; Go AS; Navaneethan SD; Chen J; He J; Bhat ZY; Jaar BG; Appel LJ; Matsushita K;
    Am J Kidney Dis; 2023 Aug; 82(2):225-236. PubMed ID: 36935072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.
    Seiler S; Rogacev KS; Roth HJ; Shafein P; Emrich I; Neuhaus S; Floege J; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1049-58. PubMed ID: 24677555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Longitudinal B-Type Natriuretic Peptide Monitoring With Kidney Failure in Patients With CKD: A Cohort Study.
    Oka T; Sakaguchi Y; Hattori K; Asahina Y; Kajimoto S; McCallum W; Tighiouart H; Sarnak MJ; Kaimori JY; Isaka Y
    Am J Kidney Dis; 2023 Nov; 82(5):559-568. PubMed ID: 37354935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
    Silva AP; Mendes F; Carias E; Gonçalves RB; Fragoso A; Dias C; Tavares N; Café HM; Santos N; Rato F; Leão Neves P; Almeida E
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
    Zhan M; Doerfler RM; Xie D; Chen J; Chen HY; Diamantidis CJ; Rahman M; Ricardo AC; Sondheimer J; Strauss L; Wagner LA; Weir MR; Fink JC;
    Am J Kidney Dis; 2020 Aug; 76(2):184-193. PubMed ID: 32317121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.
    Lash JP; Ricardo AC; Roy J; Deo R; Fischer M; Flack J; He J; Keane M; Lora C; Ojo A; Rahman M; Steigerwalt S; Tao K; Wolf M; Wright JT; Go AS;
    Am J Kidney Dis; 2016 Oct; 68(4):545-553. PubMed ID: 27209443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraprocessed Foods and Kidney Disease Progression, Mortality, and Cardiovascular Disease Risk in the CRIC Study.
    Sullivan VK; Appel LJ; Anderson CAM; Kim H; Unruh ML; Lash JP; Trego M; Sondheimer J; Dobre M; Pradhan N; Rao PS; Chen J; He J; Rebholz CM;
    Am J Kidney Dis; 2023 Aug; 82(2):202-212. PubMed ID: 37028638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frailty and Cardiovascular Outcomes in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Hannan M; Chen J; Hsu J; Zhang X; Saunders MR; Brown J; McAdams-DeMarco M; Mohanty MJ; Vyas R; Hajjiri Z; Carmona-Powell E; Meza N; Porter AC; Ricardo AC; Lash JP;
    Am J Kidney Dis; 2024 Feb; 83(2):208-215. PubMed ID: 37741609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.